2017 Announcements
Appendix 4D and Half Year Report
24 February 2017
Your Directors present their report on the Company and its controlled entities for the half year ended 31 December 2016.
The result from ordinary activities attributable to CLINUVEL PHARMACEUTICALS LIMITED for the half year was a net profit of $2,522,519, representing a 177% improvement to the financial result for the same period last year (a net loss of $3,261,046).